Abstract

Botulinum neurotoxins (BoNTs) produced by Clostridia species are the most potent identified natural toxins. Classically, the toxic neurological syndrome is characterized by an (afebrile) acute symmetric descending flaccid paralysis. The most know typical clinical syndrome of botulism refers to the foodborne form. All different forms are characterized by the same symptoms, caused by toxin-induced neuromuscular paralysis. The diagnosis of botulism is essentially clinical, as well as the decision to apply the specific antidotal treatment. The role of the laboratory is mandatory to confirm the clinical suspicion in relation to regulatory agencies, to identify the BoNTs involved and the source of intoxication. The laboratory diagnosis of foodborne botulism is based on the detection of BoNTs in clinical specimens/food samples and the isolation of BoNT from stools. Foodborne botulism intoxication is often underdiagnosed; the initial symptoms can be confused with more common clinical conditions (i.e., stroke, myasthenia gravis, Guillain–Barré syndrome—Miller–Fisher variant, Eaton–Lambert syndrome, tick paralysis and shellfish or tetrodotoxin poisoning). The treatment includes procedures for decontamination, antidote administration and, when required, support of respiratory function; few differences are related to the different way of exposure.

Highlights

  • Botulinum neurotoxins (BoNTs) are the most powerful natural toxins and are mainly related to Clostridia species

  • The length of the neurons that innervate the cranial muscles is short, with consequent poor tertiary deposit; facial muscles are continuously active, with a prevalence of phasic fibers, high neurotransmitter turnover and rapid internalization of toxin; few receptors are present at postsynaptic facial muscular membrane level that, more quickly, suffer from the lack of acetylcholine

  • The laboratory confirmation of foodborne botulism is possible with the detection of BoNTs in clinical specimens or food samples and on the isolation of BoNT producing clostridia from stools

Read more

Summary

Introduction

Botulinum neurotoxins (BoNTs) are the most powerful natural toxins and are mainly related to Clostridia species. Botulism of unknown source is mentioned by some authors [3] All this different forms are clinically characterized by the same syndrome, due to the toxin-induced neuromuscular paralysis. C. botulinum capable of producing type B toxin and isolated from an infant botulism case. A first description of nosocomial transmission of C. butyricum type E responsible for two cases of Infant Botulism (IB) has been recently described in two patients came from different geographical area. This experience underlines the importance of apply correct procedures to prevent nosocomial transmission of Clostridium difficile colitis and to reduce spreading of neurotoxins producing clostridia spores [7]. An early clinical diagnosis is crucial to manage appropriately the intoxicated patient with supportive and antidote treatment

History
Toxic Mechanism of Human Foodborne Botulism
Clinical syndrome of Human Foodborne Botulism
Diagnosis and Differential Diagnosis
Key Points for Differential Diagnosis
Gastrointestinal Decontamination
Antidotes
Supportive Airway Treatment
Antibiotic Therapy
Experimental Treatments
Botulism and Pregnancy
Findings
Conclusive Remarks
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.